Scannell Timothy J
SEC Form 4 insider trading activity
Scannell Timothy J has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including MASI, NVCR, PODD, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Scannell Timothy J is listed as Director at NovoCure Ltd. Inside the rolling window, Scannell Timothy J reported no open-market purchases and 1 open-market sale totaling $46K in NVCR.
Companies traded
Other insiders at MASI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$46K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Scannell Timothy J made?
Scannell Timothy J has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including MASI, NVCR, PODD since 2026.
Which companies does Scannell Timothy J trade?
Scannell Timothy J has filed SEC Form 4 disclosures for 3 companies, including MASI, NVCR, PODD.
When was Scannell Timothy J's most recent SEC Form 4 filing?
Scannell Timothy J's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Scannell Timothy J's total buy and sell value in the current window?
Inside the rolling retention window, Scannell Timothy J bought $0 and sold $46K based on SEC Form 4 filings.
What was Scannell Timothy J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,945 NVCR shares on 2026-06-02, worth $46K, per SEC Form 4 filings.